Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan.
Previous studies on rabbit thrombomodulin (TM) revealed that certain anticoagulant activities expressed by TM depend on the presence of an acidic domain tentatively identified as a sulfated galactosaminoglycan (Bourin, M.-C., Ohlin, A.-K., Lane, D., Stenflo, J., and Lindahl, U. (1988) J. Biol. Chem. 263, 8044-8052). The glycan was released by alkaline beta-elimination, isolated by ion-exchange chromatography, and radiolabeled by partial N-deacetylation (hydrazinolysis) followed by re-N-[3H]acetylation. The labeled product behaved like standard chondroitin sulfate on ion-exchange chromatography, exhibited a Mr of 10-12 x 10(3) on gel chromatography, and was susceptible to degradation by chondroitinase and testicular hyaluronidase. The major labeled degradation products following digestion of the glycosaminoglycan with chondroitinase were identified, depending on the incubation conditions, either as 4/6-mono-O-sulfated, 4,5-unsaturated disaccharides (delta HexA-GalNAc(S] and N-acetylgalactosamine 4,6-di-O-sulfate (GalcNAc (diS], the latter component accounting for approximately 25% of the total label, or as a major fraction of labeled trisaccharide, with the predominant structure GalNAc(diS)-GlcA-GalNAc(diS). The terminal GalNAc(diS) unit (not substituted at C3) was shown to be more susceptible to N-deacetylation during hydrazinolysis than were the internal GalNAc units (substituted at C3), and thus was more extensively labeled, resulting in over-representation of this unit. It is concluded that rabbit TM is a chondroitin sulfate proteoglycan, which carries a single glycan side chain characterized by an unusual accumulation of sulfate groups at the nonreducing terminus. Metabolically 35S-labeled TM was isolated from cultured rabbit heart endothelial cells and characterized as a chondroitin sulfate proteoglycan which accounted for 1-2% of the total 35S-labeled cell-associated macromolecules. The isolated chondroitin sulfate showed weaker antithrombin-dependent anticoagulant activity, on a molar basis, than the intact TM proteoglycan. The anticoagulant action of TM thus depends on a unique form of functional collaboration between the different constituents of a glycoconjugate.
Bourin
M C
MC
Department of Veterinary Medical Chemistry, Swedish University of Agricultural Sciences, Uppsala.
Lundgren-Akerlund
E
E
Lindahl
U
U
D000818:Animals; D002478:Cells, Cultured; D002808:Chondroitin Lyases; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D004590:Electrophoresis, Paper; D004727:Endothelium / Q000378:metabolism; D006025:Glycosaminoglycans / Q000096:biosynthesis / Q000302:isolation & purification* / Q000378:metabolism; D011817:Rabbits; D011865:Radioisotope Dilution Technique; D011956:Receptors, Cell Surface / Q000096:biosynthesis / Q000302:isolation & purification* / Q000378:metabolism; D018179:Receptors, Thrombin; D013431:Sulfates / Q000378:metabolism; D013462:Sulfur Radioisotopes; D013917:Thrombin / Q000378:metabolism; D014316:Tritium
D006025:Glycosaminoglycans; D011956:Receptors, Cell Surface; D018179:Receptors, Thrombin; D013431:Sulfates; D013462:Sulfur Radioisotopes; D014316:Tritium; D013917:Thrombin; D002808:Chondroitin Lyases